Proficio Capital Partners LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 38,764 shares of the company’s stock, valued at approximately $39,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter worth about $26,000. UMB Bank n.a. increased its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the period. First Horizon Advisors Inc. raised its position in HealthEquity by 50.7% during the 4th quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock worth $107,000 after buying an additional 375 shares during the last quarter. Quarry LP lifted its stake in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares during the period. Finally, GAMMA Investing LLC boosted its stake in shares of HealthEquity by 32.9% in the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after buying an additional 309 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Stock Performance
Shares of HQY opened at $93.97 on Friday. The company has a 50-day moving average of $105.74 and a two-hundred day moving average of $94.94. The stock has a market cap of $8.14 billion, a P/E ratio of 86.21, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on HQY shares. BTIG Research boosted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Raymond James boosted their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.
Check Out Our Latest Research Report on HealthEquity
Insider Buying and Selling
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.20% of the stock is currently owned by company insiders.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Insider Buying Explained: What Investors Need to Know
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What is the NASDAQ Stock Exchange?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.